首页> 外国专利> USE OF PYRIMIDINE DERIVATIVE FOR TREATING EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO AGENT TARGETING EGFR FAMILY MEMBERS

USE OF PYRIMIDINE DERIVATIVE FOR TREATING EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO AGENT TARGETING EGFR FAMILY MEMBERS

机译:使用嘧啶衍生物治疗EGFR依赖的疾病或对靶向EGFR家庭成员有抗药性的获得性疾病

摘要

PROBLEM TO BE SOLVED: To provide a method for treating EGFR(epidermal growth factor receptor) family member-dependent diseases or diseases with acquired resistance to a treatment agent for the diseases.SOLUTION: This invention provides a pyrimidine derivative of the following formula. There are also provided a method for treating diseases in combination with an EGFR modulator; and a pharmaceutical preparation for treating diseases comprising the compound, alone or in combination with an EGFR modulator.
机译:解决的问题:提供一种治疗EGFR(表皮生长因子受体)家族成员依赖性疾病或对所述疾病的治疗剂具有获得性抗性的方法。解决方案:本发明提供下式的嘧啶衍生物。还提供了与EGFR调节剂组合治疗疾病的方法。以及用于治疗疾病的药物制剂,其包含单独或与EGFR调节剂组合的化合物。

著录项

  • 公开/公告号JP2014040446A

    专利类型

  • 公开/公告日2014-03-06

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号JP20130206606

  • 申请日2013-10-01

  • 分类号A61K31/5377;A61P35;A61K45;A61P43;A61K31/517;A61K39/395;

  • 国家 JP

  • 入库时间 2022-08-21 16:15:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号